AVT 01
Alternative Names: AVT-01 decoy ODN; AVT-01 decoy oligodeoxynucleotide; AVT01Latest Information Update: 03 Jan 2020
At a glance
- Originator University of Gottingen
- Developer DOLTHERA
- Class Anti-inflammatories; Antiasthmatics; Oligonucleotides
- Mechanism of Action STAT1 transcription factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 03 Jan 2020 AnGes MG is now called AnGes
- 13 Mar 2014 Activaero GmbH has been acquired by Vectura
- 22 Jan 2008 AVT 01 is still in phase IIa trials for asthma in the UK and Romania